Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Clinical trial NCT07164976 · RECRUITING

Trial details

NCT number

NCT07164976

Sponsor

Nagoya City University

Status

RECRUITING

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2025-10-01

Primary completion

2029-09-01

Enrollment

86

View on ClinicalTrials.gov